AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Jun 7, 2011
33422_dirs_2011-06-06_ddb391e9-74fe-4997-9a36-ec38839d42e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (PRWP.OB)
CIK: 0001133416
Period of Report: 2011-06-02
Reporting Person: FREEMAN KEVIN D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-02 | Employee Stock Option (right to buy) | $1.25 | A | 96000 | Acquired | 2021-06-02 | Common Stock (96000) | Direct |
Footnotes
F1: The option vests quarterly in eight equal installments beginning September 2, 2011.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21